Medrad has introduced a new injection system for delivering contrastmedia during CT procedures. The Pittsburgh company's EnVisionCTTM product is smaller and more compact than previous injectionsystems and features touch-screen monitor control,
Medrad has introduced a new injection system for delivering contrastmedia during CT procedures. The Pittsburgh company's EnVisionCTTM product is smaller and more compact than previous injectionsystems and features touch-screen monitor control, front-loadsyringe engagement and automatic syringe filling. Medrad has receivedFood and Drug Administration clearance for the product.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.